Eterna Therapeutics (ERNA) 10-K 2006 FY Annual report

EXHIBIT 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

Board of Directors

NTN Buzztime, Inc. and Subsidiaries

We consent to the incorporation by reference in the registration statements (No. 333-122024, No. 333-60814, No. 333-17247, No. 333-12777 and No. 033-95776) on Form S-8 and in the registration statements (No. 333-111538, No. 333-105429, No. 333-51650, No. 333-80143, No. 333-69383, No. 333-40625, and No. 333-14129) on Form S-3 of NTN Buzztime, Inc. and Subsidiaries of our report dated March 12, 2007, relating to the consolidated balance sheets of NTN Buzztime, Inc. and Subsidiaries as of December 31, 2006 and 2005 and the related consolidated statements of operations, comprehensive income (loss), shareholders’ equity, and cash flows for each of the years in the three-year period ended December 31, 2006, the 2006 and 2005 information in the related financial statement schedule, and our report on management’s assessment of the effectiveness of internal control over financial reporting and the effectiveness of internal control over financial reporting as of December 31, 2006, which report appears in the Annual Report on Form 10-K of NTN Buzztime, Inc. and Subsidiaries as of and for the year ended December 31, 2006.

HASKELL & WHITE LLP

Irvine, California

March 12, 2007